Adverse events in patients with MDR TB, treated by three types of the chemotherapy regimens

Conclusion: Inclusion of the new drugs in MDR TB treatment regimens didn’t increase the number of AE and SAE and didn’t substantially modify or extend the AE/SAE spectrum. So, the new regimen can be widely implemented in the all categories of patients.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Rodina, O., Borisov, S. E., Ivanova, D. Tags: Tuberculosis Source Type: research